An OB/GYN at a southeast integrated health network has expertise in menopause, sexual health, general and high-risk obstetrics, and surgery. This stakeholder believes private investment will accelerate innovation in this space, not public NIH funding. Key unmet needs are considered research, prognostics, a gold standard for testing and treatment, and reimbursement. They believe PCOS, pregnancy complications, and perinatal conditions have the highest unmet needs today. The greatest increase in precision medicine activity in the next 1-2 years is expected in pregnancy complications, perinatal conditions, and menopause. This stakeholder is excited by activity from the Jada System, Novocuff, PeriGen, an Astellas (particularly for their menopause drug Fezolinetant). This stakeholder is also excited for a potential upcoming drug for postpartum depression.
PDF deck with summarized feedback from stakeholders
Individual PDFs of call transcripts with stakeholders
This package includes both the PDF deck and transcripts, providing a comprehensive understanding of stakeholders' views. You will receive a summarized report in the form of a PDF deck, as well as the full transcript of the discussions.
Individual call transcript of a single stakeholder discussing their views. This option is ideal for those who are interested in a specific stakeholder's perspective and insights on the topic.